Allianz opens Friday with sector comparison, shares steady against European peers

By Julia Schmitt, Sector & Peer Group desk. Reviewed prior to publication on 2026-06-26, 14:26.

Allianz SE (DE0008404005) enters Friday trading with investors focused on how the large German insurer stacks up against major European peers such as AXA and Zurich Insurance on valuation, capital strength and dividend yield. The group remains a heavyweight in the Stoxx Europe 600 and a key constituent of the DAX, which keeps the stock in global benchmark portfolios.

How Allianz compares with peers

Allianz SE most recently reported its quarterly figures for the first quarter of 2026, confirming a solid operating profit performance and a robust Solvency II ratio at group level, as detailed in its investor relations materials. The insurer continues to emphasize capital discipline and predictable cash returns to shareholders through dividends and buybacks, which is a central point for long-only investors in the European insurance sector. Allianz investor relations overview of financials and capital position

Large European peers such as AXA and Zurich Insurance also highlight strong Solvency metrics and dividends, creating a competitive landscape where investors compare payout ratios, growth rates and sensitivity to interest rates. Allianz SE, as a DAX component traded in Frankfurt and on Xetra, is often contrasted with these peers on price to earnings and price to book ratios in sector reports prepared by brokerage houses. Market commentary frequently notes the stability of the insurance sector relative to banks when rates normalize, and Allianz is a reference name in that discussion. Reuters sector focus on European insurers and capital returns

Analyst views on Allianz shares

Sell-side analysts from large houses such as Deutsche Bank, UBS and JPMorgan regularly update their views on Allianz SE, focusing on earnings visibility, reserve adequacy and the sustainability of the dividend. Consensus data collected by aggregators indicates a mix of Buy and Hold ratings, with only a limited number of Underperform calls, reflecting a generally constructive stance on the stock within the European insurance space. Analysts often contrast Allianz with AXA on property-casualty exposure and with Zurich on capital allocation, which helps portfolio managers decide between these names. MarketScreener consensus overview for Allianz SE

Recent notes from research houses have discussed the impact of higher interest rates on investment income and life insurance guarantees, suggesting that Allianz SE may benefit from improved reinvestment yields while managing duration risk. At the same time, analysts flag exposure to natural catastrophe events in the property-casualty segment, which requires careful risk management and reinsurance purchasing. The shares are typically assessed against sector valuation averages in the Stoxx Europe 600 insurance sub-index, with attention to discount or premium levels relative to historic ranges. Finanzen.net analyst summaries for Allianz shares

Where Allianz earns its money

Allianz SE generates revenue from a broad mix of insurance and asset management activities, including property-casualty insurance, life and health insurance, and investment management through Allianz Global Investors and PIMCO. The group operates in many countries, with Europe as its core region but significant businesses also in the United States and Asia. Premium income, fees and commissions, and investment income together form the main sources of profit, with risk diversification across different product lines and geographies.

Trading details for Allianz stock

Allianz SE shares trade on Xetra and the Frankfurt Stock Exchange, with the stock listed in euros and included in the DAX and Stoxx Europe 600 indices. As of 2026-06-26, 14:26, the price per share is around 250 euros according to indicative exchange data, reflecting the current market assessment of the group's earnings power and capital position.

This article was produced with AI assistance and editorially reviewed. Price and company figures without guarantee; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions carry risks up to and including total loss.